Luke Evnin

CIK: 0001134657

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)88 (97.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (1.1%)

Compensation grants

Other (G, F, J, C, D, …)1 (1.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HOWL

Werewolf Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (90 total)

HOWL
Werewolf Therapeutics, Inc.
Jul 7, 2026
Sale(S)
Indirect
107.4K shares at avg. $0.31$33K
HOWL
Werewolf Therapeutics, Inc.
Jul 6, 2026
Sale(S)
Indirect
35.8K shares at avg. $0.32$11K
HOWL
Werewolf Therapeutics, Inc.
Jun 29, 2026
Sale(S)
Indirect
157.1K shares at avg. $0.30$47K
HOWL
Werewolf Therapeutics, Inc.
Jun 9, 2026
Sale(S)
Indirect
76.9K shares at avg. $0.37$28K
HOWL
Werewolf Therapeutics, Inc.
Jun 8, 2026
Sale(S)
Indirect
60.5K shares at avg. $0.40$24K
HOWL
Werewolf Therapeutics, Inc.
Jun 5, 2026
Sale(S)
Indirect
24.9K shares at avg. $0.40$10K
HOWL
Werewolf Therapeutics, Inc.
Jun 4, 2026
Sale(S)
Indirect
20.1K shares at avg. $0.44$9K
HOWL
Werewolf Therapeutics, Inc.
Jun 3, 2026
Sale(S)
Indirect
29.7K shares at avg. $0.42$12K
HOWL
Werewolf Therapeutics, Inc.
Jun 2, 2026
Sale(S)
Indirect
29.6K shares at avg. $0.45$13K
HOWL
Werewolf Therapeutics, Inc.
Jun 1, 2026
Sale(S)
Indirect
80.5K shares at avg. $0.47$38K
HOWL
Werewolf Therapeutics, Inc.
May 29, 2026
Sale(S)
Indirect
32.6K shares at avg. $0.45$15K
HOWL
Werewolf Therapeutics, Inc.
May 28, 2026
Sale(S)
Indirect
27.7K shares at avg. $0.46$13K
HOWL
Werewolf Therapeutics, Inc.
May 27, 2026
Sale(S)
Indirect
80.9K shares at avg. $0.48$39K
HOWL
Werewolf Therapeutics, Inc.
May 26, 2026
Sale(S)
Indirect
68K shares at avg. $0.47$32K
HOWL
Werewolf Therapeutics, Inc.
May 22, 2026
Sale(S)
Indirect
87.4K shares at avg. $0.45$39K
HOWL
Werewolf Therapeutics, Inc.
May 21, 2026
Sale(S)
Indirect
36.4K shares at avg. $0.42$15K
HOWL
Werewolf Therapeutics, Inc.
May 20, 2026
Sale(S)
Indirect
85.9K shares at avg. $0.43$37K
HOWL
Werewolf Therapeutics, Inc.
May 19, 2026
Sale(S)
Indirect
63K shares at avg. $0.45$28K
HOWL
Werewolf Therapeutics, Inc.
May 18, 2026
Sale(S)
Indirect
22.2K shares at avg. $0.50$11K
HOWL
Werewolf Therapeutics, Inc.
May 13, 2026
Sale(S)
Indirect
44.7K shares at avg. $0.54$24K
HOWL
Werewolf Therapeutics, Inc.
May 12, 2026
Sale(S)
Indirect
67.9K shares at avg. $0.64$43K
HOWL
Werewolf Therapeutics, Inc.
May 11, 2026
Sale(S)
Indirect
33.9K shares at avg. $0.67$23K
HOWL
Werewolf Therapeutics, Inc.
May 8, 2026
Sale(S)
Indirect
305.7K shares at avg. $0.70$214K
HOWL
Werewolf Therapeutics, Inc.
May 7, 2026
Sale(S)
Indirect
79.1K shares at avg. $0.63$50K
HOWL
Werewolf Therapeutics, Inc.
May 6, 2026
Sale(S)
Indirect
14.6K shares at avg. $0.66$10K

		Type	Shares	Price		Ownership
Jul 7, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	107,429	$0.31	$33,303	Indirect
Jul 6, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	35,770	$0.32	$11,446	Indirect
Jun 29, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	157,084	$0.30	$47,125	Indirect
Jun 9, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	76,928	$0.37	$28,463	Indirect
Jun 8, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	60,547	$0.40	$24,219	Indirect
Jun 5, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	24,946	$0.40	$9,978	Indirect
Jun 4, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	20,072	$0.44	$8,832	Indirect
Jun 3, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	29,749	$0.42	$12,495	Indirect
Jun 2, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	29,595	$0.45	$13,318	Indirect
Jun 1, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	80,459	$0.47	$37,816	Indirect
May 29, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	32,556	$0.45	$14,650	Indirect
May 28, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	27,698	$0.46	$12,741	Indirect
May 27, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	80,852	$0.48	$38,809	Indirect
May 26, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	67,950	$0.47	$31,937	Indirect
May 22, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	87,425	$0.45	$39,341	Indirect
May 21, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	36,387	$0.42	$15,283	Indirect
May 20, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	85,895	$0.43	$36,935	Indirect
May 19, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	62,970	$0.45	$28,337	Indirect
May 18, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	22,184	$0.50	$11,092	Indirect
May 13, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	44,679	$0.54	$24,127	Indirect
May 12, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	67,885	$0.64	$43,446	Indirect
May 11, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	33,948	$0.67	$22,745	Indirect
May 8, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	305,741	$0.70	$214,019	Indirect
May 7, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	79,086	$0.63	$49,824	Indirect
May 6, 2026	HOWL Werewolf Therapeutics, Inc.	Sale(S)	14,635	$0.66	$9,659	Indirect

1-25 of 90 transactions

About EVNIN LUKE

EVNIN LUKE (SEC CIK 0001134657) files insider reports with the SEC as Director of Werewolf Therapeutics, Inc. (HOWL).

Signal8 holds 33 ownership filings by EVNIN LUKE, all Form 4s, filed between Apr 30, 2025 and Jul 8, 2026. Those filings report 90 transactions, from Mar 27, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on EVNIN LUKE's filings is in BOSTON, MA.

Recent filings by EVNIN LUKE

Jul 7, 2026: Open-market sale of HOWL shares (Form 4, code S).
Jul 6, 2026: Open-market sale of HOWL shares (Form 4, code S).
Jun 29, 2026: Open-market sale of HOWL shares (Form 4, code S).
Jun 9, 2026: Open-market sale of HOWL shares (Form 4, code S).
Jun 8, 2026: Open-market sale of HOWL shares (Form 4, code S).

Other insiders filing for Werewolf Therapeutics, Inc. (HOWL)

RA CAPITAL MANAGEMENT, L.P., 10% Owner
Urban Michael J., VP of Finance & Corp. Contr.
MPM BioVentures 2014, L.P., 10% Owner
GADICKE ANSBERT, 10% Owner
Lazarus Alon, Director
Morrison Briggs, Director

How to read Form 4 transaction codes